2023-07-27 09:50:41 ET
- Reata Pharmaceuticals ( NASDAQ: RETA ) ticked up 2% amid some takeover speculation.
- There's some speculation that Reata Pharma ( RETA ) has attracted takeover interest, according to a Betaville "uncooked" alert, which cited people following the matter. At least two large industry players, including a U.S. company, may be looking at RETA.
- Earlier this month, TD Cowen started Reata ( RETA ) at an outperform, citing the sales potential of the ataxia drug.
- Reata ( RETA ) short interest is 14%.
For further details see:
Reata Pharmaceuticals ticks higher amid takeover speculation